Targeting Cellular Senescence in Senile Osteoporosis: Therapeutic Potential of Traditional Chinese Medicine

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2023 Dec 11

PMID 38076228

Authors

Yingyi Zhang

Xinfeng Yu

Chengcong Zhou

Keqi Fu

Huan Luo

Chengliang Wu

Affiliations

Soon will be listed here.

Abstract

Senile osteoporosis (SOP) is a prevalent manifestation of age-related bone disorders, resulting from the dysregulation between osteoblast (OB)-mediated bone formation and osteoclast (OC)-mediated bone resorption, coupled with the escalating burden of cellular senescence. Traditional Chinese medicine (TCM) herbs, renowned for their remarkable attributes encompassing excellent tolerability, low toxicity, heightened efficacy, and minimal adverse reactions, have gained considerable traction in OP treatment. Emerging evidence substantiates the therapeutic benefits of various TCM formulations and their active constituents, including Zuogui wan, , and Resveratrol, in targeting cellular senescence to address SOP. However, a comprehensive review focusing on the therapeutic efficacy of TCM against SOP, with a particular emphasis on senescence, is currently lacking. In this review, we illuminate the pivotal involvement of cellular senescence in SOP and present a comprehensive exploration of TCM formulations and their active ingredients derived from TCM, delineating their potential in SOP treatment through their anti-senescence properties. Notably, we highlight their profound effects on distinct aging models that simulate SOP and various senescence characteristics. Finally, we provide a forward-looking discussion on utilizing TCM as a strategy for targeting cellular senescence and advancing SOP treatment. Our objective is to contribute to the unveiling of safer and more efficacious therapeutic agents for managing SOP.

References

Moiseeva O, Deschenes-Simard X, St-Germain E, Igelmann S, Huot G, Cadar A . Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation. Aging Cell. 2013; 12(3):489-98. DOI: 10.1111/acel.12075. View

Bian Q, Liu S, Huang J, Yang Z, Tang D, Zhou Q . Oleanolic acid exerts an osteoprotective effect in ovariectomy-induced osteoporotic rats and stimulates the osteoblastic differentiation of bone mesenchymal stem cells in vitro. Menopause. 2011; 19(2):225-33. DOI: 10.1097/gme.0b013e3182272ef1. View

Zhang N, Han T, Huang B, Rahman K, Jiang Y, Xu H . Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery. J Ethnopharmacol. 2016; 189:61-80. DOI: 10.1016/j.jep.2016.05.025. View

Wang Q, Huang P, Xia C, Fu D . Network pharmacology-based strategy to investigate pharmacological mechanism of Liuwei Dihuang Pill against postmenopausal osteoporosis. Medicine (Baltimore). 2022; 101(47):e31387. PMC: 9704901. DOI: 10.1097/MD.0000000000031387. View

Kang X, Chen L, Yang S, Gong Z, Hu H, Zhang X . Zuogui Wan slowed senescence of bone marrow mesenchymal stem cells by suppressing Wnt/β-catenin signaling. J Ethnopharmacol. 2022; 294:115323. DOI: 10.1016/j.jep.2022.115323. View

Wang J, Chen W, Wen C, Hung S, Chen P, Chiu J . Du-Huo-Ji-Sheng-Tang and its active component Ligusticum chuanxiong promote osteogenic differentiation and decrease the aging process of human mesenchymal stem cells. J Ethnopharmacol. 2017; 198:64-72. DOI: 10.1016/j.jep.2016.12.011. View

Yu Y, Wu J, Li J, Liu Y, Zheng X, Du M . Cycloastragenol prevents age-related bone loss: Evidence in d-galactose-treated and aged rats. Biomed Pharmacother. 2020; 128:110304. DOI: 10.1016/j.biopha.2020.110304. View

Wang R, Wang Y, Zhu L, Liu Y, Li W . Epigenetic Regulation in Mesenchymal Stem Cell Aging and Differentiation and Osteoporosis. Stem Cells Int. 2020; 2020:8836258. PMC: 7501554. DOI: 10.1155/2020/8836258. View

Farr J, Fraser D, Wang H, Jaehn K, Ogrodnik M, Weivoda M . Identification of Senescent Cells in the Bone Microenvironment. J Bone Miner Res. 2016; 31(11):1920-1929. PMC: 5289710. DOI: 10.1002/jbmr.2892. View

10.

Ren Z, Raut N, Lawal T, Patel S, Lee S, Mahady G . Peonidin-3-O-glucoside and cyanidin increase osteoblast differentiation and reduce RANKL-induced bone resorption in transgenic medaka. Phytother Res. 2021; 35(11):6255-6269. PMC: 8942084. DOI: 10.1002/ptr.7271. View

11.

Hu L, Yin C, Zhao F, Ali A, Ma J, Qian A . Mesenchymal Stem Cells: Cell Fate Decision to Osteoblast or Adipocyte and Application in Osteoporosis Treatment. Int J Mol Sci. 2018; 19(2). PMC: 5855582. DOI: 10.3390/ijms19020360. View

12.

Hussain T, Tan B, Yin Y, Blachier F, Tossou M, Rahu N . Oxidative Stress and Inflammation: What Polyphenols Can Do for Us?. Oxid Med Cell Longev. 2016; 2016:7432797. PMC: 5055983. DOI: 10.1155/2016/7432797. View

13.

Khosla S, Farr J, Tchkonia T, Kirkland J . The role of cellular senescence in ageing and endocrine disease. Nat Rev Endocrinol. 2020; 16(5):263-275. PMC: 7227781. DOI: 10.1038/s41574-020-0335-y. View

14.

Li M, Yu Y, Xue K, Li J, Son G, Wang J . Genistein mitigates senescence of bone marrow mesenchymal stem cells via ERRα-mediated mitochondrial biogenesis and mitophagy in ovariectomized rats. Redox Biol. 2023; 61:102649. PMC: 9995482. DOI: 10.1016/j.redox.2023.102649. View

15.

Wu Y, Hu Y, Zhao Z, Xu L, Chen Y, Liu T . Protective Effects of Water Extract of against Oxidative Stress-Related Osteoporosis In Vivo and In Vitro. Vet Sci. 2021; 8(9). PMC: 8473267. DOI: 10.3390/vetsci8090198. View

16.

Raut N, Wicks S, Lawal T, Mahady G . Epigenetic regulation of bone remodeling by natural compounds. Pharmacol Res. 2019; 147:104350. PMC: 6733678. DOI: 10.1016/j.phrs.2019.104350. View

17.

Liu N, Qi B, Zhang Y, Fang S, Sun C, Li Q . Bu-Gu-Sheng-Sui decoction promotes osteogenesis activating the ERK/Smad signaling pathways. Front Pharmacol. 2022; 13:976121. PMC: 9453880. DOI: 10.3389/fphar.2022.976121. View

18.

Sun P, Zhang Y, Wei Z, Wang Z, Guo S, Lin Y . Effect of Qing'e Decoction on Leptin/Leptin Receptor and Bone Metabolism in Naturally Aging Rats. Evid Based Complement Alternat Med. 2020; 2020:2532081. PMC: 7520685. DOI: 10.1155/2020/2532081. View

19.

Yu T, You X, Zhou H, Kang A, He W, Li Z . p53 plays a central role in the development of osteoporosis. Aging (Albany NY). 2020; 12(11):10473-10487. PMC: 7346075. DOI: 10.18632/aging.103271. View

20.

Liu Y, You M, Shen J, Xu Y, Li L, Wang D . Allicin Reversed the Process of Frailty in Aging Male Fischer 344 Rats With Osteoporosis. J Gerontol A Biol Sci Med Sci. 2019; 75(5):821-825. PMC: 7164536. DOI: 10.1093/gerona/glz205. View